Download PDF
Semin Reprod Med 2012; 30(05): 427-431
DOI: 10.1055/s-0032-1324727
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

DSD Due to 5α-Reductase 2 Deficiency - from Diagnosis to Long Term Outcome

Elaine M.F. Costa
1   Division of Endocrinology Unit, Hormone and Molecular Genetics Laboratory, Medical School, University of São Paulo
2   Division of Endocrinology, Hospital das Clinicas of the University of São Paulo, School of Medicine, São Paulo, Brazil
,
Sorahia Domenice
1   Division of Endocrinology Unit, Hormone and Molecular Genetics Laboratory, Medical School, University of São Paulo
2   Division of Endocrinology, Hospital das Clinicas of the University of São Paulo, School of Medicine, São Paulo, Brazil
,
Maria Helena Sircili
1   Division of Endocrinology Unit, Hormone and Molecular Genetics Laboratory, Medical School, University of São Paulo
2   Division of Endocrinology, Hospital das Clinicas of the University of São Paulo, School of Medicine, São Paulo, Brazil
,
Marlene Inacio
1   Division of Endocrinology Unit, Hormone and Molecular Genetics Laboratory, Medical School, University of São Paulo
2   Division of Endocrinology, Hospital das Clinicas of the University of São Paulo, School of Medicine, São Paulo, Brazil
,
Berenice B. Mendonca
1   Division of Endocrinology Unit, Hormone and Molecular Genetics Laboratory, Medical School, University of São Paulo
2   Division of Endocrinology, Hospital das Clinicas of the University of São Paulo, School of Medicine, São Paulo, Brazil
› Author Affiliations
Further Information

Publication History

Publication Date:
08 October 2012 (online)

    Permissions and Reprints

Abstract

Most of the patients with 5α-RD 2 deficiency are reared in the female social sex due to their severely undervirilized external genitalia but ~60% who have not been submitted to orchiectomy in childhood undergo male social sex change at puberty. In our cohort of 30 cases from 18 families, all subjects were registered in the female social sex except for two children—one who had an affected uncle and the other who was diagnosed before being registered. The majority of the patients were satisfied with the long-term results of their treatment and surprisingly, penile length was not associated with satisfactory or unsatisfactory sexual activity.

Steroid 5α-RD2 deficiency should be included in the differential diagnosis of all newborns with 46,XY DSD with normal testosterone production before gender assignment or any surgical intervention because these patients should be considered males at birth.

Keywords

5α-reductase 2 deficiency - disorders of sexual development - outcome
 

  • References

  • 1 Imperato-McGinley J, Guerrero L, Gautier T, Peterson RE. Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974; 186 (4170) 1213-1215
    CrossrefPubMedGoogle Scholar
  • 2 Walsh PC, Madden JD, Harrod MJ, Goldstein JL, MacDonald PC, Wilson JD. Familial incomplete male pseudohermaphroditism, type 2. Decreased dihydrotestosterone formation in pseudovaginal perineoscrotal hypospadias. N Engl J Med 1974; 291 (18) 944-949
    CrossrefPubMedGoogle Scholar
  • 3 Nowakowski H, Lenz W. Genetic aspects in male hypogonadism. Recent Prog Horm Res 1961; 17: 53-95
    PubMedGoogle Scholar
  • 4 Imperato-McGinley J, Zhu YS. Androgens and male physiology the syndrome of 5alpha-reductase-2 deficiency. Mol Cell Endocrinol 2002; 198 (1–2) 51-59
    CrossrefPubMedGoogle Scholar
  • 5 Maimoun L, Philibert P, Cammas B , et al. Phenotypical, biological, and molecular heterogeneity of 5α-reductase deficiency: an extensive international experience of 55 patients. J Clin Endocrinol Metab 2011; 96 (2) 296-307
    CrossrefPubMedGoogle Scholar
  • 6 Cai LQ, Zhu YS, Katz MD , et al. 5 alpha-reductase-2 gene mutations in the Dominican Republic. J Clin Endocrinol Metab 1996; 81 (5) 1730-1735
    CrossrefPubMedGoogle Scholar
  • 7 Byne W. Developmental endocrine influences on gender identity: implications for management of disorders of sex development. Mt Sinai J Med 2006; 73 (7) 950-959
    PubMedGoogle Scholar
  • 8 Bahceci M, Ersay AR, Tuzcu A, Hiort O, Richter-Unruh A, Gokalp D. A novel missense mutation of 5-alpha reductase type 2 gene (SRD5A2) leads to severe male pseudohermaphroditism in a Turkish family. Urology 2005; 66 (2) 407-410
    CrossrefPubMedGoogle Scholar
  • 9 Ocal G, Adiyaman P, Berberoğlu M , et al. Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J Pediatr Endocrinol Metab 2002; 15 (4) 411-421
    PubMedGoogle Scholar
  • 10 Boudon C, Lobaccaro JM, Lumbroso S , et al. A new deletion of the 5 alpha-reductase type 2 gene in a Turkish family with 5 alpha-reductase deficiency. Clin Endocrinol (Oxf) 1995; 43 (2) 183-188
    CrossrefPubMedGoogle Scholar
  • 11 Canto P, Vilchis F, Chávez B , et al. Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. Clin Endocrinol (Oxf) 1997; 46 (2) 155-160
    CrossrefPubMedGoogle Scholar
  • 12 Vilchis F, Canto P, Chávez B, Ulloa-Aguirre A, Méndez JP. Molecular analysis of the 5 alpha-steroid reductase type 2 gene in a family with deficiency of the enzyme. Am J Med Genet 1997; 69 (1) 69-72
    CrossrefPubMedGoogle Scholar
  • 13 Vilchis F, Méndez JP, Canto P, Lieberman E, Chávez B. Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin Endocrinol (Oxf) 2000; 52 (3) 383-387
    CrossrefPubMedGoogle Scholar
  • 14 Hafez M, Mazen I, Ghali I, Sultan C, Lumbroso S. A new mutation of 5-alpha-reductase type 2 (A62E) in a large Egyptian kindred. Horm Res 2003; 59 (6) 281-284
    CrossrefPubMedGoogle Scholar
  • 15 Imperato-McGinley J, Miller M, Wilson JD, Peterson RE, Shackleton C, Gajdusek DC. A cluster of male pseudohermaphrodites with 5 alpha-reductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf) 1991; 34 (4) 293-298
    CrossrefPubMedGoogle Scholar
  • 16 Griffin J , et al. The androgen resistance syndrome: Steroid 5a-reductase 2 deficiency, testicular feminization, and related disorders., in The metabolic and molecular bases of inherited disease, B.A. Scriver CR, Sly WS, Vale D, Editor 2000, McGraw-Hill: New York.
    Google Scholar
  • 17 Thigpen AE, Davis DL, Milatovich A , et al. Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 1992; 90 (3) 799-809
    CrossrefPubMedGoogle Scholar
  • 18 Cohen-Kettenis PT. Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 2005; 34 (4) 399-410
    CrossrefPubMedGoogle Scholar
  • 19 Warne GL, Raza J. Disorders of sex development (DSDs), their presentation and management in different cultures. Rev Endocr Metab Disord 2008; 9 (3) 227-236
    CrossrefPubMedGoogle Scholar
  • 20 Jenkins EP, Andersson S, Imperato-McGinley J, Wilson JD, Russell DW. Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J Clin Invest 1992; 89 (1) 293-300
    CrossrefPubMedGoogle Scholar
  • 21 Russell DW, Wilson JD. Steroid 5 alpha-reductase: two genes/two enzymes. Annu Rev Biochem 1994; 63: 25-61
    CrossrefPubMedGoogle Scholar
  • 22 Thigpen AE, Silver RI, Guileyardo JM, Casey ML, McConnell JD, Russell DW. Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest 1993; 92 (2) 903-910
    CrossrefPubMedGoogle Scholar
  • 23 Silver RI, Wiley EL, Thigpen AE, Guileyardo JM, McConnell JD, Russell DW. Cell type specific expression of steroid 5 alpha-reductase 2. J Urol 1994; 152 (2 Pt 1) 438-442
    PubMedGoogle Scholar
  • 24 Mendonca BB, Inacio M, Costa EM , et al. Male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Diagnosis, psychological evaluation, and management. Medicine (Baltimore) 1996; 75 (2) 64-76
    CrossrefPubMedGoogle Scholar
  • 25 Mendoca B, Costa E, Belgorosky A, Rivarola M, Domenice S. 46,XY DSD due to impaired androgen production. Best Pract Res Clin Endocrinol Meta B 2010; 24 (2) 243-262
    PubMedGoogle Scholar
  • 26 Berra M, Williams EL, Muroni B , et al. Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic. Eur J Endocrinol 2011; 164 (6) 1019-1025
    CrossrefPubMedGoogle Scholar
  • 27 Ng WK, Taylor NF, Hughes IA, Taylor J, Ransley PG, Grant DB. 5 alpha-reductase deficiency without hypospadias. Arch Dis Child 1990; 65 (10) 1166-1167
    CrossrefPubMedGoogle Scholar
  • 28 Cai LQ, Fratianni CM, Gautier T, Imperato-McGinley J. Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency. J Clin Endocrinol Metab 1994; 79 (2) 409-414
    CrossrefPubMedGoogle Scholar
  • 29 Hochberg Z, Chayen R, Reiss N , et al. Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. J Clin Endocrinol Metab 1996; 81 (8) 2821-2827
    CrossrefPubMedGoogle Scholar
  • 30 Mendonça BB, Batista MC, Arnhold IJ , et al. Male pseudohermaphroditism due to 5 alpha reductase deficiency associated with gynecomastia. Rev Hosp Clin Fac Med Sao Paulo 1987; 42 (2) 66-68
    PubMedGoogle Scholar
  • 31 Chávez B, Valdez E, Vilchis F. Uniparental disomy in steroid 5alpha-reductase 2 deficiency. J Clin Endocrinol Metab 2000; 85 (9) 3147-3150
    CrossrefPubMedGoogle Scholar
  • 32 Hiort O, Sinnecker GH, Willenbring H, Lehners A, Zöllner A, Struve D. Nonisotopic single strand conformation analysis of the 5 alpha-reductase type 2 gene for the diagnosis of 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1996; 81 (9) 3415-3418
    CrossrefPubMedGoogle Scholar
  • 33 Thiele S, Hoppe U, Holterhus PM, Hiort O. Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males. Eur J Endocrinol 2005; 152 (6) 875-880
    CrossrefPubMedGoogle Scholar
  • 34 Imperato-McGinley J, Peterson RE, Gautier T, Sturla E. Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency—a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid Biochem 1979; 11 (1B) 637-645
    CrossrefPubMedGoogle Scholar
  • 35 Walter KN, Kienzle FB, Frankenschmidt A , et al. Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD. Horm Res Paediatr 2010; 74 (1) 67-71
    CrossrefPubMedGoogle Scholar
  • 36 Bertelloni S, Scaramuzzo RT, Parrini D, Baldinotti F, Tumini S, Ghirri P. Early diagnosis of 5alpha-reductase deficiency in newborns. Sex Dev 2007; 1 (3) 147-151
    CrossrefPubMedGoogle Scholar
  • 37 Imperato-McGinley J, Gautier T, Pichardo M, Shackleton C. The diagnosis of 5 alpha-reductase deficiency in infancy. J Clin Endocrinol Metab 1986; 63 (6) 1313-1318
    CrossrefPubMedGoogle Scholar
  • 38 Imperato-McGinley J. 5 alpha-reductase-2 deficiency. Curr Ther Endocrinol Metab 1997; 6: 384-387
    PubMedGoogle Scholar
  • 39 Perry RJ, Novikova E, Wallace AM, Donaldson MD. Pitfalls in the diagnosis of 5α-reductase type 2 deficiency during early infancy. Horm Res Paediatr 2011; 75 (5) 380-382
    CrossrefPubMedGoogle Scholar
  • 40 Hackel C, Oliveira LE, Ferraz LF , et al. New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2. J Mol Med (Berl) 2005; 83 (7) 569-576
    CrossrefPubMedGoogle Scholar
  • 41 Wilson JD, Griffin JE, Russell DW. Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 1993; 14 (5) 577-593
    CrossrefPubMedGoogle Scholar
  • 42 Nicoletti A, Baldazzi L, Balsamo A , et al. SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf) 2005; 63 (4) 375-380
    CrossrefPubMedGoogle Scholar
  • 43 Mazen I, Gad YZ, Hafez M, Sultan C, Lumbroso S. Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation. Clin Endocrinol (Oxf) 2003; 58 (5) 627-631
    CrossrefPubMedGoogle Scholar
  • 44 Vilchis F, Ramos L, Méndez JP, Benavides S, Canto P, Chávez B. Molecular analysis of the SRD5A2 in 46,XY subjects with incomplete virilization: the P212R substitution of the steroid 5alpha-reductase 2 may constitute an ancestral founder mutation in Mexican patients. J Androl 2010; 31 (4) 358-364
    CrossrefPubMedGoogle Scholar
  • 45 Maimoun L, Philibert P, Bouchard P , et al. Primary amenorrhea in four adolescents revealed 5α-reductase deficiency confirmed by molecular analysis. Fertil Steril 2011; 95 (2) 804-805 , e1–e5
    PubMedGoogle Scholar
  • 46 Mendonca BB, Domenice S, Arnhold IJ, Costa EM. 46,XY disorders of sex development (DSD). Clin Endocrinol (Oxf) 2009; 70 (2) 173-187
    CrossrefPubMedGoogle Scholar
  • 47 Costa EM, Mendonca BB, Inácio M, Arnhold IJ, Silva FA, Lodovici O. Management of ambiguous genitalia in pseudohermaphrodites: new perspectives on vaginal dilation. Fertil Steril 1997; 67 (2) 229-232
    CrossrefPubMedGoogle Scholar
  • 48 Khen-Dunlop N, Lortat-Jacob S, Thibaud E, Clément-Ziza M, Lyonnet S, Nihoul-Fekete C. Rokitansky syndrome: clinical experience and results of sigmoid vaginoplasty in 23 young girls. J Urol 2007; 177 (3) 1107-1111
    CrossrefPubMedGoogle Scholar
  • 49 Dénes FT, Cocuzza MA, Schneider-Monteiro ED , et al. The laparoscopic management of intersex patients: the preferred approach. BJU Int 2005; 95 (6) 863-867
    CrossrefPubMedGoogle Scholar
  • 50 Sircili MH, , e Silva FA, Costa EM. , et al. Long-term surgical outcome of masculinizing genitoplasty in large cohort of patients with disorders of sex development. J Urol 2010; 184 (3) 1122-1127
    CrossrefPubMedGoogle Scholar
  • 51 Sircili MH, de Mendonca BB, Denes FT, Madureira G, Bachega TA , e Silva FA. Anatomical and functional outcomes of feminizing genitoplasty for ambiguous genitalia in patients with virilizing congenital adrenal hyperplasia. Clinics (Sao Paulo) 2006; 61 (3) 209-214
    PubMedGoogle Scholar
  • 52 Powell CR, Mcaleer I, Alagiri M, Kaplan GW. Comparison of flaps versus grafts in proximal hypospadias surgery. J Urol 2000; 163 (4) 1286-1288 , discussion 1288–1289
    CrossrefPubMedGoogle Scholar
  • 53 Ferro F, Zaccara A, Spagnoli A, Lucchetti MC, Capitanucci ML, Villa M. Skin graft for 2-stage treatment of severe hypospadias: back to the future?. J Urol 2002; 168 (4 Pt 2) 1730-1733 , discussion 1733
    CrossrefPubMedGoogle Scholar
  • 54 Nihoul-Fékété C, Thibaud E, Lortat-Jacob S, Josso N. Long-term surgical results and patient satisfaction with male pseudohermaphroditism or true hermaphroditism: a cohort of 63 patients. J Urol 2006; 175 (5) 1878-1884
    CrossrefPubMedGoogle Scholar
  • 55 Hughes IA, Houk C, Ahmed SF, Lee PA ; LWPES Consensus Group; ESPE Consensus Group. Consensus statement on management of intersex disorders. Arch Dis Child 2006; 91 (7) 554-563
    PubMedGoogle Scholar
  • 56 Migeon CJ, Wisniewski AB, Gearhart JP , et al. Ambiguous genitalia with perineoscrotal hypospadias in 46,XY individuals: long-term medical, surgical, and psychosexual outcome. Pediatrics 2002; 110 (3) e31
    CrossrefPubMedGoogle Scholar
  • 57 Mendonca BB Male pseudohermaphroditism in http://WWW.ENDOTEXT.ORG website, M. New, Editor 2007, MDTEXT.COM, INC, S. DARTMOUTH,MA.
    PubMed